| Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL (NCT06321289) | Chinese PLA General Hospital | 2024-03-20 |
| An Acupuncture Study for People At High Risk for Sepsis (NCT06344819) | University of California, Irvine | 2024-03-20 |
| Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study (NCT06301399) | Tianjin Medical University Cancer Institute and Hospital | 2024-03-20 |
| Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma (NCT06194929) | University of Utah | 2024-03-20 |
| A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL (NCT06375733) | Genfleet Therapeutics (Shanghai) Inc. | 2024-03-20 |
| Defibrotide Dose-escalation for SOS Post-HSCT (NCT05987124) | New York Medical College | 2024-03-20 |
| A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer (NCT06237257) | Shanghai Shengdi Pharmaceutical Co., Ltd | 2024-03-20 |
| Statin Addition to Chemotherapy for Advanced Pancreatic Cancer (NCT06241352) | Changhai Hospital | 2024-03-20 |
| A Study of the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (NCT06337071) | Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | 2024-03-20 |
| A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder (NCT06267846) | Neurocrine Biosciences | 2024-03-20 |
| A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC) (NCT06333678) | Memorial Sloan Kettering Cancer Center | 2024-03-20 |
| Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder (NCT05995769) | University of Calgary | 2024-03-20 |
| Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. (NCT06145074) | Zealand University Hospital | 2024-03-20 |
| A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer. (NCT06339216) | Chinese PLA General Hospital | 2024-03-20 |
| Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK) (NCT06221670) | Tianjin Medical University Cancer Institute and Hospital | 2024-03-20 |
| A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B (NCT06566248) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-03-20 |
| CX-4945 in Viral Community Acquired Pneumonia (NCT06202521) | Senhwa Biosciences, Inc. | 2024-03-20 |
| A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (NCT06463834) | Fujian Cancer Hospital | 2024-03-20 |
| Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair (NCT07446933) | Zagazig University | 2024-03-20 |
| Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD (NCT06315465) | All India Institute of Medical Sciences | 2024-03-20 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease (NCT06268886) | Bristol-Myers Squibb | 2024-03-20 |
| Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression (NCT06375083) | VA Eastern Colorado Health Care System | 2024-03-20 |
| A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity (NCT06264453) | HysensBio Co., Ltd | 2024-03-19 |
| Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms (NCT06767813) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-03-19 |
| Tranexamic Acid in Nasal Mohs Reconstruction (NCT06057675) | Vanderbilt University Medical Center | 2024-03-19 |
| CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth (NCT05405413) | Dartmouth-Hitchcock Medical Center | 2024-03-19 |
| TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma (NCT06301165) | Sun Yat-sen University | 2024-03-19 |
| A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS) (NCT06242652) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-03-19 |
| A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis (NCT06220669) | Eli Lilly and Company | 2024-03-19 |
| A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma (NCT06261359) | Qilu Pharmaceutical Co., Ltd. | 2024-03-19 |
| Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis (NCT06300203) | Beijing Tongren Hospital | 2024-03-18 |
| Strategy for Improving Stroke Treatment Response (NCT05948566) | Translational Sciences, Inc. | 2024-03-18 |
| A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight (NCT06326060) | Novo Nordisk A/S | 2024-03-18 |
| Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment (NCT06159283) | Jaehoon Ko | 2024-03-18 |
| A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder (NCT06340958) | Clexio Biosciences Ltd. | 2024-03-18 |
| Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy (NCT06331585) | Hetian District People's Hospital | 2024-03-18 |
| NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101 (NCT05984810) | Leiden University Medical Center | 2024-03-18 |
| A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes (NCT06326047) | Novo Nordisk A/S | 2024-03-18 |
| Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (NCT06253663) | Kite, A Gilead Company | 2024-03-18 |
| A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses (NCT06136403) | Centre Hospitalier Universitaire de Nice | 2024-03-18 |
| A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines (NCT06353971) | Jasper Therapeutics, Inc. | 2024-03-18 |
| Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor (NCT06289166) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2024-03-18 |
| Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality (NCT06191289) | University of Illinois at Chicago | 2024-03-16 |
| Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (NCT06252441) | Tanta University | 2024-03-16 |
| A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer (NCT06312982) | Beijing Friendship Hospital | 2024-03-16 |
| LEARNER- Low dosE AspiRiN prEterm tRial (Angola) (NCT06417411) | Instituto Nacional de Investigacao em Saude, Angola | 2024-03-16 |
| Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE) (NCT04597437) | George Washington University | 2024-03-15 |
| Effects of Different Doses of Intravenous Lidocaine Infusion on Peri-operative Pain and Incidence of Postoperative Chronic Pain Within ERAS Protocols, a Dose Finding Study. (NCT06431165) | Cairo University | 2024-03-15 |
| A Study of TAVO101 in Atopic Dermatitis Patients (NCT06176040) | Tavotek Biotherapeutics | 2024-03-15 |
| HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan (NCT06236269) | SOLTI Breast Cancer Research Group | 2024-03-15 |
| A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib (NCT06378892) | Centro di Riferimento Oncologico - Aviano | 2024-03-15 |
| Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab (NCT06304545) | Harbin Medical University | 2024-03-15 |
| A Study of ANAVEX3-71 in Adults With Schizophrenia (NCT06245213) | Anavex Life Sciences Corp. | 2024-03-15 |
| To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome (NCT06849973) | Biomed Industries, Inc. | 2024-03-15 |
| A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC. (NCT06306560) | Harbin Medical University | 2024-03-15 |
| Study the Effect of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Level in Hemodialysis Patients (NCT06421883) | Al-Azhar University | 2024-03-15 |
| Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma (NCT06108232) | M.D. Anderson Cancer Center | 2024-03-15 |
| Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN) (NCT06122922) | Bastiaan Driehuys | 2024-03-15 |
| The IMPACT Implementation-Effectiveness Trial (NCT06323707) | McMaster University | 2024-03-15 |
| Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (NCT06321913) | Harbin Medical University | 2024-03-15 |
| A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma (NCT06512428) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2024-03-15 |
| Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer (NCT06233877) | Hirschfeld Oncology | 2024-03-15 |
| Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm (NCT06219915) | University of Michigan | 2024-03-15 |
| SGLT2i in Diabetic Patients with Renal Transplantation (NCT06731231) | Ain Shams University | 2024-03-15 |
| A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer (NCT06308406) | Jiangsu HengRui Medicine Co., Ltd. | 2024-03-15 |
| Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery (NCT06201884) | Centre Francois Baclesse | 2024-03-15 |
| Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock (NCT06306001) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2024-03-15 |
| Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial (NCT05608434) | National Institute of Mental Health (NIMH) | 2024-03-15 |
| Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients (NCT06406140) | Al-Azhar University | 2024-03-15 |
| A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients (NCT06255704) | Shanxi Province Cancer Hospital | 2024-03-15 |
| A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (NCT06132893) | Biohaven Therapeutics Ltd. | 2024-03-14 |
| A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP (NCT04850118) | Beacon Therapeutics | 2024-03-14 |
| Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）. (NCT06375486) | Tianjin Medical University Cancer Institute and Hospital | 2024-03-14 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants (NCT06086626) | Shionogi | 2024-03-14 |
| Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma (NCT06342167) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-03-14 |
| Mitigating PTSD-CUD After Sexual Assault (NCT05989841) | University of Nevada, Las Vegas | 2024-03-14 |
| Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors (NCT06334432) | Nuvation Bio Inc. | 2024-03-14 |
| A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma (NCT06727630) | Zhuhai Yufan Biotechnologies Co., Ltd | 2024-03-14 |
| Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease (NCT06023641) | St. Jude Children's Research Hospital | 2024-03-13 |
| Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION] (NCT06216470) | University Health Network, Toronto | 2024-03-13 |
| DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9) (NCT06539195) | Dizal Pharmaceuticals | 2024-03-13 |
| Opioid/Benzodiazepine Polydrug Abuse: Aim 3 (NCT05006079) | Wayne State University | 2024-03-13 |
| A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation (NCT06299098) | Regeneron Pharmaceuticals | 2024-03-13 |
| Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy (NCT05857371) | Assistance Publique Hopitaux De Marseille | 2024-03-13 |
| Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus (NCT06032923) | National Heart, Lung, and Blood Institute (NHLBI) | 2024-03-13 |
| Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study (NCT06158113) | University of North Carolina, Chapel Hill | 2024-03-13 |
| Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty (NCT06234631) | Chad Brummett | 2024-03-13 |
| Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients (NCT06332079) | Gruppo Oncologico del Nord-Ovest | 2024-03-13 |
| Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response (NCT06175000) | Providence Health & Services | 2024-03-13 |
| Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma (NCT06318286) | Hyogo Medical University | 2024-03-13 |
| Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases (NCT06285539) | UMC Utrecht | 2024-03-12 |
| The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome (NCT06824324) | Yassir R. Al-khannaq | 2024-03-12 |
| Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label (NCT05494398) | Stanford University | 2024-03-12 |
| Study of AZD0754 in Participants With Metastatic Prostate Cancer (NCT06267729) | AstraZeneca | 2024-03-12 |
| A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM (NCT06590259) | Shanghai 6th People's Hospital | 2024-03-12 |
| A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma (NCT05046314) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-03-12 |
| Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer (NCT05231122) | Roswell Park Cancer Institute | 2024-03-12 |
| A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT05991349) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-03-12 |
| Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression (NCT06088732) | Laureate Institute for Brain Research, Inc. | 2024-03-12 |
| Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC) (NCT06437223) | Inflammx Therapeutics Inc | 2024-03-12 |